Yes. Obesity is increasingly recognised as a chronic, relapsing, treatable condition, not a personal failing. After weight loss the body increases hunger hormones, reduces fullness signals and lowers energy expenditure, which is why weight so often returns whatever the method used. Understanding this does not remove personal responsibility, but it explains why long-term support is needed, and why treatments that act on appetite biology, such as Mounjaro, Wegovy, the Wegovy pill and Foundayo, are part of modern care alongside nutrition, strength training and behavioural support.
A chronic condition is one that is long-lasting, usually does not resolve by itself, and needs ongoing management. High blood pressure and type 2 diabetes are familiar examples. Nobody tells a person with high blood pressure that they simply need more willpower, and nobody expects the condition to be cured by a few months of treatment and then forgotten.
Obesity is increasingly viewed in the same way. Clinical definitions describe it as a chronic, progressive, relapsing and treatable condition in which excess body fat affects how the body works, with metabolic, physical and psychological consequences. In 2025 a Lancet Diabetes and Endocrinology Commission proposed distinguishing between excess body fat that is not yet affecting organ function and “clinical obesity”, where it is causing ongoing illness or limiting daily activity, to help focus treatment where it is most needed.
This fits with how UK guidance approaches care. See our guides to NHS eligibility for weight-loss injections and our BMI calculator, which look at BMI alongside weight-related health conditions.
Worth knowing
Calling obesity a disease does not mean everyone with a higher weight is unwell, or that everyone needs medication. It means that where weight is affecting health, it deserves the same evidence-based, non-judgemental care as any other long-term condition.
Body weight is tightly regulated by communication between the gut, fat tissue and the brain. Several of these signals change after weight loss, and not in a helpful direction.
| System | What it does | What changes after weight loss |
|---|---|---|
| Ghrelin (hunger hormone) | Rises before meals and stimulates appetite | Rises Increases after calorie restriction and, in one study, was still raised 62 weeks later |
| Satiety hormones (PYY, CCK, amylin) | Signal fullness to the brain after eating | Fall Meals feel less satisfying |
| Leptin | Made in fat tissue; signals long-term energy stores | Falls In obesity the brain can respond less well to it (leptin resistance) |
| Reward and dopamine pathways | Drive the pleasure and motivation around food | Altered Can intensify cravings and persistent thoughts about food |
Hunger is not a character flaw
This is the central point of the research. When someone loses weight, the body behaves as though it is under threat. Hunger rises, fullness signals weaken, and the brain pays more attention to food. A person who feels hungrier after losing weight is not failing; their physiology is doing what it evolved to do. Understanding this can reduce guilt and self-blame, which in turn supports healthier long-term habits.
“Food noise”
Many people describe constant, intrusive thinking about food, often called food noise. It is not a recognised diagnosis, but it reflects the reward and appetite pathways described above. Many people taking GLP-1 based medicines report that it quietens, which is one reason these treatments feel so different from dieting alone. See how they work in our guides to how Foundayo works and what the Wegovy pill is.
Weight depends on the balance between energy in and energy out. Energy out has three parts: the energy used at rest (roughly 60-75% of the total), physical activity (around 15-30%), and the energy used to digest food (around 10%).
| Part of daily energy use | Approximate share |
|---|---|
| Energy used at rest (basal metabolic rate) | 60-75% |
| Physical activity (exercise and everyday movement) | 15-30% |
| Digesting food (thermic effect) | About 10% |
Two things follow. First, because most energy is used at rest, exercise on its own has limited power to drive weight loss, though it is very valuable for health, fitness and preserving muscle. See our Mounjaro, Wegovy, Wegovy pill and Foundayo muscle preservation guides. Second, as weight falls the body often lowers its energy use a little more than the loss of body mass alone would predict, a process called metabolic adaptation. The size of this effect varies between people and between studies, but the direction is consistent: after weight loss the body tends to need slightly less energy than expected, which narrows the margin for error. Our calorie deficit calculator can help you work out a sensible intake.
Why Weight Comes BackResearch on weight regain, including a widely cited review by Kevin Hall and colleagues, identifies several overlapping reasons. None of them is simply a lack of effort.
- Falling energy expenditure as weight is lost
- Increased appetite and reduced fullness signals
- An environment full of calorie-dense food and low everyday movement
- A lack of support specifically aimed at maintaining weight, not just losing it
- Stopping treatment, whether that is a medicine, a programme or a structured plan
This is why regain is seen after dieting, surgery and medicines alike, and why health bodies stress that maintenance deserves as much attention as the initial loss. See our guides on maintaining weight loss after Wegovy and Foundayo, on Mounjaro maintenance, and on what to do when weight stalls: the Mounjaro, Wegovy and Foundayo plateau guides.
Willpower Versus Biology: What the Evidence Says| Common belief | What the evidence shows |
|---|---|
| “It’s just calories in, calories out” | True as arithmetic, but appetite and energy use are themselves regulated by hormones and the brain, and both change after weight loss |
| “If I try harder I’ll keep it off” | Hunger signals stay elevated for a year or more after weight loss, so maintenance is a biological challenge, not only a motivational one |
| “Exercise will fix it” | Exercise is important for health and muscle, but most daily energy use happens at rest |
| “Medication is the easy way out” | Treatments act on the same appetite pathways that are disrupted, in the way blood pressure medicines act on blood pressure |
| “Once I’ve lost it, I’m done” | Obesity is chronic; most people need ongoing support to maintain results |
Weight stigma, the belief that a person’s weight reflects their character, is associated with worse mental health and can discourage people from seeking care. Explaining the biology can help patients and clinicians move away from blame. A person who understands that their hunger is driven by hormones is better placed to ask for help, stay in treatment and make changes they can sustain.
Where Medicines Fit InMedicines such as Mounjaro (tirzepatide), Wegovy (semaglutide) and Foundayo (orforglipron) work on gut hormone and brain pathways involved in appetite and fullness. In other words, they target some of the biological systems described above, rather than relying on resisting hunger through effort alone. They are prescription-only medicines, they are licensed for specific groups, and they are intended to be used alongside a reduced-calorie diet and increased physical activity. If you are comparing options, see our Wegovy v Mounjaro v Wegovy pill decision guide, pill or injection comparison and Foundayo eligibility guide.
Because obesity is chronic, treatment is typically seen as ongoing. Some people continue long term, some move to a lower licensed dose, and some plan a stop with a maintenance strategy. See our guides on long-term use of the Wegovy pill, and the dose schedules for Mounjaro, Wegovy and Foundayo.
What Good Long-Term Care Looks LikeClinical guidance, including NICE’s guideline on managing overweight and obesity, emphasises a whole-person approach rather than a single intervention.
| Pillar | What it involves |
|---|---|
| Food and nutrition | Nutrient-dense, mostly whole foods with enough protein, which also helps preserve muscle. See our nutrition guide |
| Physical activity | More movement overall, with resistance training to protect lean mass |
| Medical treatment | Evidence-based medicines where appropriate, with regular review. See weight loss treatments for men and weight loss for men over 40 |
| Behaviour change | Structured support, self-monitoring and skills for the long term |
| Ongoing follow-up | Reviews that continue after the first weight loss, including a plan for maintenance |
Questions to ask at a review
- What is my plan for maintaining weight once I reach my goal?
- Which dose is the lowest that keeps my progress steady?
- How will we monitor blood pressure, blood sugar and cholesterol?
- What support is there for food, protein and strength training?
- What would we do if weight starts to return?
Thinking of obesity as chronic does not mean a life sentence. It means shifting the question from “why can’t I stick to it?” to “what support will I need to keep going?” That might include medication for as long as it helps, structured habits that make good choices easier, regular weigh-ins to catch changes early, and a clinical team that treats a rise in weight as a signal to adjust the plan, not as a failure. If you have skin concerns after significant weight loss, see our loose skin guide.
The bottom line
Obesity is best understood as a chronic, relapsing condition shaped by biology, environment and behaviour. Weight regain is a predictable biological response, not a moral failing, which is why long-term, whole-person support matters. Talk to our team via our weight loss consultation or browse the full guide library.
Ready to Talk About Long-Term Support?
Our GPhC-registered pharmacy team can look at your health, goals and whether treatment is right for you.
Start Your Free Online Consultation → Use code SWITCH10 if you're switching from another provider Happy Pharmacy is a GPhC-registered pharmacy (No. 9013192) — Superintendent Pharmacist: Palvinder Deol — Rated 4.8★ Excellent on Trustpilot- Sumithran P, et al. Long-term persistence of hormonal adaptations to weight loss. N Engl J Med. 2011;365:1597-1604.
- Hall KD, Kahan S. Maintenance of lost weight and long-term management of obesity. Med Clin North Am. 2018;102(1):183-197.
- Rubino F, et al. Definition and diagnostic criteria of clinical obesity. Lancet Diabetes Endocrinol. 2025.
- Fitch AK, et al. Obesity Pillars. 2022;1:100004 (definition of obesity as a chronic disease).
- Sainz N, et al. Leptin resistance and diet-induced obesity: central and peripheral actions of leptin. Metabolism. 2015;64(1):35-46.
- Knuth ND, et al. Metabolic adaptation following massive weight loss is related to the degree of energy imbalance and changes in circulating leptin. Obesity. 2014;22(12):2563-2569.
- Fonseca DC, et al. Clin Nutr Exp. 2018;20:55-59 (components of total daily energy expenditure).
- NICE. Overweight and obesity management (NG246). 2025.
- Mounjaro®, Wegovy® and Foundayo®: UK Summaries of Product Characteristics, electronic Medicines Compendium (emc).